FDA’s FY22 budget priorities: boost inspections, surveillance; avert device shortages

Regulatory NewsRegulatory NewsAudit/inspectionComplianceMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicySupply Chain Management